Publication	Data		Fish	Anatomy
Drummond et al., 2022	Figure 1		osr1zf3911/zf3911; zf3912Tg ,   osr1zf3911/zf3911	intermediate mesoderm pax2a expression decreased distribution, abnormal pericardium edematous, abnormal pronephric glomerulus absence of anatomical entity, abnormal pronephric glomerulus slit diaphragm nphs1 expression decreased distribution, abnormal pronephric podocyte wt1a expression decreased distribution, abnormal pronephric podocyte wt1b expression decreased distribution, abnormal pronephric tubule cdh17 expression decreased distribution, abnormal pronephric tubule absence of anatomical entity, abnormal pronephric tubule GFP expression decreased distribution, abnormal pronephros cdh17 expression decreased distribution, abnormal pronephros wt1b expression decreased distribution, abnormal pronephros structure, abnormal renal filtration decreased process quality, abnormal
	Figure 2		osr1zf3911/zf3911 ,   WT + MO2-osr1	angioblastic mesenchymal cell apoptotic process increased process quality, abnormal intermediate mesoderm apoptotic process increased process quality, abnormal pronephric podocyte apoptotic process increased process quality, abnormal
	Figure 3		osr1zf3911/zf3911	pronephric podocyte wt1b expression decreased distribution, abnormal pronephric tubule cdh17 expression decreased distribution, abnormal
	Figure 5		osr1zf3911/zf3911 ,   WT + MO2-osr1	intermediate mesoderm wnt2ba expression decreased distribution, abnormal pronephric glomerulus slit diaphragm nphs1 expression absent, abnormal pronephric podocyte wnt2ba expression absent, abnormal pronephric podocyte wt1b expression absent, abnormal pronephric podocyte absence of anatomical entity, abnormal pronephric tubule wnt2ba expression absent, abnormal
	Figure 6		osr1zf3911/zf3911	pronephric podocyte wnt2ba expression decreased distribution, abnormal pronephric podocyte wt1b expression decreased distribution, abnormal pronephric tubule wnt2ba expression decreased distribution, abnormal
Terashima et al., 2014	Fig. 6		AB/TU + MO2-osr1	endodermal cell differentiation increased occurrence, abnormal hypoblast has extra parts of type endodermal cell, abnormal
	Fig. 7		AB/TU + MO2-osr1	endodermal cell differentiation increased occurrence, abnormal hypoblast has extra parts of type endodermal cell, abnormal
Tomar et al., 2014	Fig. 4		AB/TU + MO2-osr1	pronephric duct anterior region slc4a2a expression absent, abnormal pronephric glomerulus morphogenesis disrupted, abnormal pronephric podocyte nphs1 expression absent, abnormal pronephric podocyte nphs2 expression absent, abnormal pronephric podocyte mislocalised, abnormal pronephric proximal tubule development disrupted, abnormal
	Fig. 5		AB/TU + MO2-osr1	intermediate mesoderm anterior region lhx1a expression absent, abnormal podocyte differentiation disrupted, abnormal pronephric podocyte nphs1 expression absent, abnormal
Neto et al., 2012	Fig. 1		WT + MO1-osr1	pectoral fin decreased size, abnormal pectoral fin development disrupted, abnormal
	Table 1		WT + MO2-osr1	pectoral fin decreased size, abnormal pectoral fin development disrupted, abnormal
Mudumana et al., 2008	Fig. 10		AB/TU + MO2-osr1	endoderm development disrupted, abnormal pharyngeal endoderm increased width, abnormal presumptive endoderm increased width, abnormal
	Fig. 11		AB/TU + MO2-osr1	pronephric tubule morphology, abnormal pronephros development disrupted, abnormal
	Fig. 3		AB/TU + MO2-osr1	pronephric proximal convoluted tubule morphology, abnormal pronephric tubule aplastic, abnormal pronephric tubule morphology, abnormal pronephros development disrupted, abnormal
	Fig. 4		AB/TU + MO2-osr1	pronephric glomerulus aplastic, abnormal pronephric podocyte morphology, abnormal pronephric proximal convoluted tubule morphology, abnormal pronephros development disrupted, abnormal
	Fig. 5		AB/TU + MO2-osr1	hemangioblast cell differentiation disrupted, abnormal
	Fig. 7		AB/TU + MO2-osr1	caudal vein plexus dilated, abnormal common cardinal vein increased diameter, abnormal pronephric glomerulus aplastic, abnormal pronephric tubule aplastic, abnormal pronephric tubule decreased diameter, abnormal
	Fig. 8		AB/TU + MO2-osr1	anterior lateral mesoderm morphology, abnormal pronephric proximal convoluted tubule morphology, abnormal pronephros development disrupted, abnormal
	Fig. 9		AB/TU + MO2-osr1	anterior lateral plate mesoderm morphology, abnormal intermediate mesoderm morphology, abnormal
	Fig. S4		AB/TU + MO2-osr1	intermediate mesodermal cell differentiation disrupted, abnormal lateral mesodermal cell differentiation disrupted, abnormal pronephros morphology, abnormal
Tena et al., 2007	Fig. 4		AB + MO1-osr1	pericardium edematous, abnormal pronephros cystic, abnormal pronephros decreased size, abnormal